Noticias de BTAI_US

Noticias del mercado

Últimas noticias sobre BTAI_US — 84 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: BTAI_US ✕ 84 resultados
23/04/2026 BTAI_US — TradingView
BTAI: IGALMI targets a vast at-home market for acute agitation, with launch readiness for 2027
23/04/2026 BTAI_US — MarketScreener ES ← EN
Transcripción: BioXcel Therapeutics, Inc. - Convocatoria especial
23/04/2026 BTAI_US — Xã Thanh Hà
BTAI (BioXcel Therapeutics Inc.) reports narrower Q4 2025 loss than expected, shares gain 7.48 percent on upbeat investor reaction. - NCAV
22/04/2026 BTAI_US — tayninh.gov.vn
BTAI BioXcel Therapeutics Inc. gains 7.48 percent after posting narrower than expected Q4 2025 EPS results.
22/04/2026 BTAI_US — laocai.gov.vn
BTAI (BioXcel Therapeutics Inc.) reports narrower Q4 2025 loss than expected, shares gain 7.48 percent on upbeat investor reaction. - Decline Phase
22/04/2026 BTAI_US — Xã Châu Thành ES ← EN
BTAI BioXcel Therapeutics Inc. gana un 7,48 por ciento después de publicar resultados de EPS del cuarto trimestre de 2025 más estrechos de lo esperado. - Red de señales de inversión

BTAI BioXcel Therapeutics Inc. gana un 7,48 por ciento después de publicar resultados de EPS del cuarto trimestre de 2025 más estrechos de lo esperado. - Red de señales de…

18/04/2026 BTAI_US — Minichart
BioXcel Therapeutics, Inc. Enters Fourth Amended and Restated Registration Rights Agreement With Oaktree Investors
18/04/2026 BTAI_US — Sahm ES ← EN
BioXcel Therapeutics anuncia un evento virtual para discutir el plan de lanzamiento comercial basado en la evaluación de oportunidades de mercado para IGALMI® en el hogar
17/04/2026 BTAI_US — news.futunn.com
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI in the At-Home Setting
17/04/2026 BTAI_US — Investing.com
BioXcel Therapeutics issues warrants to lenders as part of credit agreement amendment
17/04/2026 BTAI_US — TipRanks
Bioxcel Issues Warrants in Private Equity Financing Deal
17/04/2026 BTAI_US — Stock Titan
BioXcel Therapeutics (NASDAQ: BTAI) grants 1,353,729 low-price warrants
17/04/2026 BTAI_US — Investing.com
BioXcel to detail IGALMI launch strategy ahead of FDA decision By Investing.com
17/04/2026 BTAI_US — Yahoo Finance
H.C. Wainwright Adjusts BioXcel Therapeutics, Inc. (BTAI) Outlook Following Capital Structure Concerns
17/04/2026 BTAI_US — Investing.com
BioXcel to detail IGALMI launch strategy ahead of FDA decision By Investing.com
17/04/2026 BTAI_US — Investing.com
BioXcel to detail IGALMI launch strategy ahead of FDA decision
17/04/2026 BTAI_US — Investing.com ES ← EN
BioXcel detallará la estrategia de lanzamiento de IGALMI antes de la decisión de la FDA Por Investing.com
17/04/2026 BTAI_US — ChartMill
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
17/04/2026 BTAI_US — Stock Titan
86M annual at-home agitation episodes shape BioXcel's IGALMI plan
17/04/2026 BTAI_US — Intellectia AI
BTAI Should I Buy

Página 1 de 5

keyboard_arrow_up